This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Population-Based Study in Metropolitan Atlanta

Benjamin Schwartz, MD; Anne Schuchat, MD; Margaret J. Oxtoby, MD; Stephen L. Cochi, MD; Allen Hightower, MS; Claire V. Broome, MD

JAMA. 1991;266(8):1112-1114.

Abstract
Objective.
—To define the incidence and clinical spectrum of group B streptococcus infection in adults. To characterize groups at increased risk for infection.

Design.
—Retrospective population-based surveillance of group B streptococcus infections occurring in adults. Patients were identified by review of microbiology records at all surveillance area hospital laboratories. Demographic and clinical data were abstracted from patient medical records.

Setting.
—Metropolitan Atlanta, Ga, 1982 through 1983.

Patients.
—We identified 70 adult patients with invasive group B streptococcus infections; 14 infections occurred in pregnant women and 56 in nonpregnant adults.

Results.
—The annual incidence of group B streptococcus infection in men and nonpregnant women was 2.4 cases per 100 000 population. Incidence increased with age and was higher in blacks than in whites. The case-fatality rate was 32%. Group B streptococcus was most often isolated from blood (71%) and soft tissue (16%). Common clinical presentations included skin and soft-tissue infection (36%), bacteremia without focus (34%), pneumonia (11%), arthritis (9%), and endocarditis (9%). Compared with the general population's risk of infection, the risk of infection in persons with diabetes mellitus was increased 10.5-fold (95% confidence interval [Cl], 7.8 to 14.4); in persons with cancer, it was increased 16.4-fold (95% CI, 11.5 to 23.3).

Conclusions.
—Group B streptococcus infections cause serious disease in adults as well as in neonates, providing an additional rationale for vaccine development. Determining the incidence of adult disease and groups at greatest risk will help in focusing prevention efforts.

(JAMA. 1991;266:1112-1114)

Author Affiliations
From the Meningitis and Special Pathogens Branch (Drs Schwartz, Schuchat, Oxtoby, Cochi, and Broome), and Statistical Services Activity (Mr Hightower), Division of Bacterial and Mycotic Diseases, Centers for Disease Control, Atlanta, Ga.

Footnotes
Reprint requests to Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control, Atlanta, GA 30333 (Dr Schuchat).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares et al.
JAMA 2008;299:2056-2065.
ABSTRACT | FULL TEXT  

Role of NADase in Virulence in Experimental Invasive Group A Streptococcal Infection
Bricker et al.
Infect. Immun. 2005;73:6562-6566.
ABSTRACT | FULL TEXT  

Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina
Lopardo et al.
J. Clin. Microbiol. 2003;41:4688-4694.
ABSTRACT | FULL TEXT  

Clonal Relationship between U.S. and French Serotype V Group B Streptococcus Isolates
Le Thomas-Bories et al.
J. Clin. Microbiol. 2001;39:4526-4528.
ABSTRACT | FULL TEXT  

Pneumococcal Virulence Factors: Structure and Function
Jedrzejas
Microbiol. Mol. Biol. Rev. 2001;65:187-207.
ABSTRACT | FULL TEXT  

Severity of Group B Streptococcal Arthritis in Selected Strains of Laboratory Mice
Puliti et al.
Infect. Immun. 2001;69:551-555.
ABSTRACT | FULL TEXT  

Role of Tumor Necrosis Factor Alpha, Interleukin-1beta , and Interleukin-6 in a Mouse Model of Group B Streptococcal Arthritis
Tissi et al.
Infect. Immun. 1999;67:4545-4550.
ABSTRACT | FULL TEXT  

Group B Streptococcal Necrotizing Fasciitis and Streptococcal Toxic Shock-Like Syndrome in Adults
Gardam et al.
Arch Intern Med 1998;158:1704-1708.
ABSTRACT | FULL TEXT  

Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Schuchat
Clin. Microbiol. Rev. 1998;11:497-513.
ABSTRACT | FULL TEXT  

Group B Streptococcus Bacteremia in Nonpregnant Adults
Munoz et al.
Arch Intern Med 1997;157:213-216.
ABSTRACT  

Case 1-1996- A 69-Year-Old Woman with Severe, Persistent Congestive Heart Failure after Treatment for Bacteremia
Shannon et al.
NEJM 1996;334:105-111.
FULL TEXT  

Comparison of Prevention Strategies for Neonatal Group B Streptococcal Infection: A Population-Based Economic Analysis
Mohle-Boetani et al.
JAMA 1993;270:1442-1448.
ABSTRACT  

A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults
Farley et al.
NEJM 1993;328:1807-1811.
ABSTRACT | FULL TEXT  

The Changing Spectrum of Group B Streptococcal Disease
Wessels and Kasper
NEJM 1993;328:1843-1844.
FULL TEXT  

Group B Streptococcal Sepsis
Cross and Opal
JAMA 1992;268:2651-2651.
ABSTRACT  

Invasive Group B Streptococcal Disease in Adults
Greenspoon
JAMA 1991;266:3283-3284.
ABSTRACT